Literature DB >> 11255233

Indole-3-propionic acid, a melatonin-related molecule, protects hepatic microsomal membranes from iron-induced oxidative damage: relevance to cancer reduction.

M Karbownik1, R J Reiter, J J Garcia, J Cabrera, S Burkhardt, C Osuna, A Lewiński.   

Abstract

Excessive free iron and the associated oxidative damage are commonly related to carcinogenesis. Among the antioxidants known to protect against iron-induced oxidative abuse and carcinogenesis, melatonin and other indole compounds recently have received considerable attention. Indole-3-propionic acid (IPA), a deamination product of tryptophan, with a structure similar to that of melatonin, is present in biological fluids and is an effective free radical scavenger. The aim of the study was to examine the effect of IPA on experimentally induced oxidative changes in rat hepatic microsomal membranes. Microsomes were preincubated in presence of IPA (10, 3, 2, 1, 0.3, 0.1, 0.01 or 0.001 mM) and, then, incubated with FeCl(3) (0.2 mM), ADP (1.7 mM) and NADPH (0.2 mM) to induce oxidative damage. Alterations in membrane fluidity (the inverse of membrane rigidity) were estimated by fluorescence spectroscopy and lipid peroxidation by measuring concentrations of malondialdehyde+4-hydroxyalkenals (MDA+4-HDA). IPA, when used in concentrations of 10, 3 or 2 mM, increased membrane fluidity, although at these concentrations it did not influence lipid peroxidation significantly. The decrease in membrane fluidity due to Fe(3+) was completely prevented by preincubation in the presence of IPA at concentrations of 10, 3, 2 or 1 mM. The enhanced lipid peroxidation due to Fe(3+) was prevented by IPA only at the highest concentration (10 mM). It is concluded that Fe(3+)-induced rigidity and, to a lesser extent, lipid peroxidation in microsomal membranes may be reduced by IPA. However, IPA in high concentrations increase membrane fluidity. Besides melatonin, IPA may be used as a pharmacological agent to protect against iron-induced oxidative damage to membranes and, potentially, against carcinogenesis. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255233

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  29 in total

1.  Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites.

Authors:  William R Wikoff; Andrew T Anfora; Jun Liu; Peter G Schultz; Scott A Lesley; Eric C Peters; Gary Siuzdak
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

2.  Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.

Authors:  Magdalena Mazagova; Lirui Wang; Andrew T Anfora; Max Wissmueller; Scott A Lesley; Yukiko Miyamoto; Lars Eckmann; Suraj Dhungana; Wimal Pathmasiri; Susan Sumner; Caroline Westwater; David A Brenner; Bernd Schnabl
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

Review 3.  Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either.

Authors:  Phillipp Hartmann; Huikuan Chu; Yi Duan; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-02-15       Impact factor: 4.052

4.  1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity.

Authors:  Zhen Zhang; Caifeng Bi; Sara M Schmitt; Yuhua Fan; Lili Dong; Jian Zuo; Q Ping Dou
Journal:  J Biol Inorg Chem       Date:  2012-10-09       Impact factor: 3.358

5.  Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature.

Authors:  Gaurav V Sarode; Kyoungmi Kim; Dorothy A Kieffer; Noreene M Shibata; Tomas Litwin; Anna Czlonkowska; Valentina Medici
Journal:  Metabolomics       Date:  2019-03-12       Impact factor: 4.290

6.  Dynamic changes of capillarization and peri-sinusoid fibrosis in alcoholic liver diseases.

Authors:  Guang-Fu Xu; Xin-Yue Wang; Gui-Ling Ge; Peng-Tao Li; Xu Jia; De-Lu Tian; Liang-Duo Jiang; Jin-Xiang Yang
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

Review 7.  Development of indole-3-propionic acid (OXIGON) for Alzheimer's disease.

Authors:  Paul E Bendheim; Burkhard Poeggeler; Eyal Neria; Vivi Ziv; Miguel A Pappolla; Daniel G Chain
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

8.  Branched chain amino acids are associated with muscle mass in functionally limited older adults.

Authors:  Michael S Lustgarten; Lori Lyn Price; Angela Chale; Edward M Phillips; Roger A Fielding
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-01       Impact factor: 6.053

9.  The role of the microbiota-gut-brain axis in neuropsychiatric disorders.

Authors:  Jaqueline S Generoso; Vijayasree V Giridharan; Juneyoung Lee; Danielle Macedo; Tatiana Barichello
Journal:  Braz J Psychiatry       Date:  2020-07-10       Impact factor: 2.697

10.  A systems-level "misunderstanding": the plasma metabolome in Huntington's disease.

Authors:  Herminia D Rosas; Gheorghe Doros; Swati Bhasin; Beena Thomas; Sona Gevorkian; Keith Malarick; Wayne Matson; Steven M Hersch
Journal:  Ann Clin Transl Neurol       Date:  2015-05-28       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.